We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma ((Mel/MelVel))

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01241708
Recruitment Status : Recruiting
First Posted : November 16, 2010
Last Update Posted : August 9, 2017
Information provided by (Responsible Party):
Hackensack University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2023
  Estimated Study Completion Date : February 2023